Delivery Order SPE2DB20D7066-SPE2DB22FC1WX
Award Date 2/1/22
Potential Completion Date 2/2/22
Potential Value $1.1K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $1,212.73, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,563,557,309 units of Lisinopril 40 mg tablets. It is a firm-fixed-price delivery order contract with a completion date of February 6, 2024. There is no set-aside designation for this award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $3,684.67, is for the delivery of 4,563,947,551 units of the pharmaceutical product Lisinopril-HCTZ 10-12.5 mg tablets. This order falls under a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00, which serves as the primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,595.76 Firm Fixed Price Delivery Order contract is for the supply of 4,564,309,749 Lisinopril 40 mg tablets. The contract has an ultimate completion date of April 18, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is for the delivery of 4,563,955,470 tablets of 10 mg Lisinopril, a common blood pressure medication, to support military treatment programs and facilities. The delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC)...
- This federal contract award, valued at $9,085.53, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order contract for the supply of 4,565,079,360 tablets of Lisinopril 10 mg, a common cardiovascular medication. The contract has an ultimate completion date of July 8, 2024 and is a Firm Fixed Price arrangement. AmerisourceBergen holds a significant Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 1,000 units of the drug Lisinopril-HCTZ 20-25 mg. The single-award, firm-fixed price delivery order, valued at $2,066.47, has a completion date of July 28, 2022. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, with a value of $12,344.29, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4,564,605,288 Lisinopril 10 mg tablets, a common blood pressure medication. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an ultimate completion date of May 15, 2024. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a subsidiary of the...
- This federal contract award, valued at $1,266.29, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order (SPE2DB22D1041|SPE2DB25FUAP8) for the supply of 4,568,175,234 tablets of the drug Lisinopril 10 mg. The contract has an ultimate completion date of May 8, 2025 and is a firm fixed-price arrangement. It is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,560,581,676 units of lisinopril 20 mg tablets, a cardiovascular medication. The contract has a ceiling value of $1,142.88 and a completion date of April 14, 2023. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has a significant...
- The Defense Logistics Agency awarded a delivery order valued at $4,131.97 to AmerisourceBergen Drug Corp for 1,000 tablets of Lisinopril 40 mg, with an ultimate completion date of September 9, 2025. This non-set-aside contract employs firm fixed price terms and represents a direct fulfillment order under AmerisourceBergen's existing contract vehicle with DLA. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued...